Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Medical Sciences Division News

Annual GP Tutors Conference 2025: Coming together in connected practice

GP tutors from across the region gathered at St Hilda’s College for the 2025 Nuffield Department of Primary Care Health Sciences GP Tutors Conference, exploring how connected practice can support flourishing and innovation in primary care education.

Oxford cancer researchers welcome UK AI for Science Strategy, highlighting the opportunity for national AI-ready cancer data

Oxford researchers have welcomed the UK government’s new AI for Science Strategy, which sets out an ambitious plan to harness artificial intelligence, sovereign supercomputing and high-quality scientific data to accelerate discovery in the life sciences.

Cognitive impairment after a stroke calls for tailored recovery treatment shows new study

A major new study recently published in Imaging Neuroscience shows that the brain location of the stroke does not always determine the symptoms.

New research collaboration to tackle ethnic inequalities in perinatal severe mental illness

A ground-breaking new study aims to transform postpartum mental health care for mothers from ethnic minority backgrounds or those living in deprived areas who experience severe mental illness.

Oxford researchers develop first live-cell assay linking cancer tumour metabolism to drug effectiveness

Scientists at the Centre for Medicines Discovery, part of Oxford University’s Nuffield Department of Medicine, have developed a biosensor that, for the first time, allows researchers to directly measure how experimental cancer drugs engage their target inside living cells dependent on co-factors and metabolites.